0 Items
Select Page

Canine Heartworm

Canine heartworm disease is a serious and potentially fatal zoonotic parasitic disease of dogs, mainly located in temperate, tropical, and subtropical areas of the world. It is caused by foot-long worms (heartworms) that live in the heart, lungs and associated blood vessels of affected dogs, causing severe lung disease, heart failure and damage to other organs in the body. Heartworm disease can also affect other mammal species, including cats, wolves, coyotes, foxes, raccoons, sea lions and, in rare cases, humans.

Canine Heartworm Background

Canine heartworm (Dirofilaria immitis) is a parasitic nematode responsible for the canine heartworm disease. Transmitted from host-to-host via mosquito bites, infection largely affects the cardiopulmonary system resulting in severe and potentially fatal disease. The disease mostly affects temperate, tropical and subtropical areas of North, Central and South America, southern Europe, and Australia.

The prevalence of the disease is largely determined by the presence of mosquito vectors, usually Culex spp, Aedes and Anopheles spp. Mosquitoes act as an intermediate stage for Dirofilaria in order to complete their life cycle. The mosquitoes become infected whilst taking a blood meal from a host,  and the microfilariae develop to the third-stage larvae (L3) in the malpighian tubules of the mosquitoes (Cancrini and Kramer, 2001), which are transmitted to the host while the mosquito is taking a blood meal, becoming sexually mature within a few months in the main pulmonary arteries and right ventricle (Morchón et al., 2012).

D. immitis adult worms can cause pulmonary artery blockage in dogs, leading to an illness that can include cough, exhaustion upon exercise, fainting, coughing up blood, and severe weight loss. Heartworm infection may result in serious complications for the host, typically culminating in the host’s death, most often as the result of secondary congestive heart failure. Wolbachia pipientis is an intracellular bacterium that is an endosymbiont of D. immitis and it is thought that all heartworms contain Wolbachia in varying amounts. These bacteria have been implicated as playing a role in the pathogenesis of filarial diseases, possibly through endotoxin production. Studies have shown that a primary surface protein of Wolbachia (WSP) induces a specific IgG response in hosts infected by D immitis (Todd-Jenkins, Karen., 2007).

There are no vaccines against canine heartworm and the only drug available to treat infection with adult heartworms is melarsomine dihydrochloride, an arsenical compound which kills both mature and some immature heartworms (Atkins, 2019). Diagnostic testing by ELISA, lateral flow immunoassay and rapid immunomigration techniques are now routinely used to detect heartworm antigen in the host’s blood and these have good levels of sensitivity and specificity.


  • Atkins C. (2019). Heartworm Disease in Dogs. Merck Sharp & Dohme Corp (MSD) Veterinary Manual.
  • Morchón (2012). Heartworm Disease (Dirofilaria immitis) and Their Vectors in Europe – New Distribution Trends. Front Physiol. 3: 196.
  • Todd-Jenkins, Karen (2007). The Role of Wolbachia in heartworm disease. Veterinary Forum. 24 (10): 28–30.

Canine Heartworm Antibodies

The Native Antigen Company has three antibodies available, which are specific to canine heartworm, and suitable for diagnostic assay development and vaccine research.


Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Why We Need Antigen and Antibody Tests for COVID-19

RT-PCR is the workhorse of viral diagnosis and has been invaluable in COVID-19 case confirmation and isolation guidance. However, while fast and sensitive, PCR suffers from some inherent drawbacks that limit it to diagnosis during the acute phase of infection. To...

Gonorrhea: What’s Currently in the Clinical Pipeline?

This article was written by our friends at Infectious Diseases Hub, a free-to-access website that aims to deliver up-to-date, essential research and information on all aspects of microbiology, virology, mycology and parasitology – from bench to bedside....

Novel Coronavirus Antigens Now Available

The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for SARS-CoV-2 (Covid-19) in response to urgent demand. These reagents are suitable for use in basic research and the development of diagnostics and vaccines.These antigens have been...

The Why and How of Protein Conjugation

In this blog, Lead Assay Development Scientist, Toni Ertl discusses the basics of protein conjugation and introduces our new range of conjugation kits for the labelling of antigens and antibodies.Detecting Proteins If you’re trying to detect or measure the presence...

Going Viral: Why We Need New Diagnostics For a Safe and Effective Dengue Vaccine

This article is taken from European Biopharmaceutical Review January 2020, pages 44-46. © Samedan Ltd.The Dengue VirusDengue is the world’s most prevalent and consequential arboviral disease. Current estimates indicate that as many as 390 million dengue infections...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

5 + 14 =

Live Customer Feedback

Join our mailing list

* indicates required